FTK at a glance
FLOTEK INDUSTRIES INC/CN/ (FTK, SEC CIK 928054) filed its latest 10-K annual report on March 16, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 3, 2026 and Form 4 insider filings as recently as November 19, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), FLOTEK INDUSTRIES INC/CN/ (FTK) reported revenue of $237.3 million (up 26.9% from FY2024) and net income of $30.5 million. Diluted EPS was $0.84.
- The most recent insider open-market sale reported on Form 4 was by Agadi Harshavardhan V on November 19, 2026 of 14,873 shares at $25.67 per share.
- In the last 90 days, FTK insiders reported 1 open-market purchase ($34.3M) and 6 open-market sales ($61.8M) on Form 4, a net sale of $27.5M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $237.3M
- +26.9% vs prior year
- Insiders · 90 days
- 1 buy · 6 sells
- Net −$27.5M
- Latest 8-K
- Nov 3, 2026
- Item 2.02 · Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- New project risk triggered by PREPA Contract termination: expected annual revenue approximately $40 million at full deployment was not realized
- New securities class action filed August 26, 2026, alleging Exchange Act and Rule 10b-5 violations tied to PREPA disclosures
- New derivative litigation filed September 23, 2026, alleging fiduciary-duty breaches and potentially requiring unreimbursed legal advances
- Utility Support Contract power generation paused by infrastructure delays, with six-month initial term subject to uncertain extension
- Emerging power-services exposure: limited operating history in infrastructure-scale generation services
Management Discussion & Analysis
- Revenue $114.4M, up 104% YoY from $56.0M
- Gross margin 24.0% vs 31.7%, operating margin 15.7% vs 16.2% YoY
- Best segment DA revenue $18.1M, up from $8.9M, with operating income $10.3M
- Cash $21.3M vs $5.7M, operating cash flow used $16.8M, financing provided $34.0M
- Outlook: remainder 2026 revenue above 2025, Utility Support Contract revenue not expected in fourth quarter
AI summary of the FTK 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Flotek reported financial results for the quarter ended September 30, 2026
- Conference call announced to discuss quarterly financial and operating performance
Item 7.01: Regulation FD Disclosure
- Investor presentation posted November 3, 2026, covering current operations and financial results
- Exhibit 99.2 contains the substantive disclosure, potentially updating investors on operating performance and outlook
Item EX-99.2: Item EX-99.2
- Q3 2026 revenue $114.4M, up 104%, with record quarterly revenue and broad-based growth across chemistry and Data Analytics
- Adjusted EBITDA $19.5M, up 87%, while net income fell 35% to $13.3M due partly to a $12.6M prior-year tax benefit
Item EX-99.1: Item EX-99.1
- Q3 revenue $114.4M, up 104% YoY, the highest quarterly level in twelve years
- Adjusted EBITDA $19.5M, up 87%, while net income fell 35% to $13.3M after a prior-year $12.6M tax benefit
Item EX-99.1: Item EX-99.1
- $75 million funded at closing, with up to $45 million in delayed-draw availability
- Proceeds refinance the existing $40 million term loan, fund Data Analytics capital expenditures, and support working capital
Item 1.02: Termination of a Material Definitive Agreement
- $40 million PWRTEK Note repaid in full using proceeds from Initial Term Loans
- 10.0% annual interest obligation eliminated before its five-year term
Item 1.01: Entry into a Material Definitive Agreement
- $75.0M senior secured term loan refinances PWRTEK Note and funds capital expenditures, working capital, and corporate purposes
- Interest at Term SOFR plus 6.50%, with 2.50% SOFR floor; default rate adds 2.00%
Item 2.03: Creation of a Direct Financial Obligation
- Item 2.03 links the company’s new financial obligations to transactions described under Item 1.01
- Investor focus: review Item 1.01 for borrowing terms, payment commitments, counterparties and potential balance-sheet impact
Item 7.01: Regulation FD Disclosure
- Press release announces closing of the Credit Agreement on September 23, 2026
- Credit agreement closing signals completion of a financing transaction, with terms and obligations detailed in Exhibit 99.1
Item EX-99.1: Item EX-99.1
- 2026 revenue guidance raised to $360–370M, implying 54% midpoint growth versus 2025
- Adjusted EBITDA guidance increased to $50–54M, implying 58% midpoint growth versus 2025
Item EX-99.2: Item EX-99.2
- 2Q26 revenue $99.4MM, up 70%, with net income $10.0MM, up 463%, and Adjusted EBITDA $16.8MM, up 109%
- FY2026 guidance raised to $360MM-$370MM revenue and $50MM-$54MM Adjusted EBITDA, the second increase this year
Item 7.01: Regulation FD Disclosure
- Updated 2026 guidance estimates announced, potentially affecting revenue and earnings expectations
- Corporate presentation updated for Lake Street Annual Investor Conference on September 10, 2026
AI summaries of FTK 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for FTK
Don't miss the next FTK filing
- Alerts as it files. A push when FTK files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut FTK, by share count.
- Ask anything. An AI agent that reads every FTK filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Agadi Harshavardhan V | Sell | Nov 19, 2026 | 14,873 | $25.67 |
| Agadi Harshavardhan V | Sell | Nov 18, 2026 | 29,710 | $25.35 |
| Agadi Harshavardhan V | Sell | Nov 18, 2026 | 3,667 | $25.00 |
| Agadi Harshavardhan V | Sell | Nov 17, 2026 | 6,750 | $25.02 |
| Agadi Harshavardhan V | Sell | Nov 13, 2026 | 15,000 | $25.27 |
| CLEMENT JAMES BOND | F | Oct 30, 2026 | 3,935 | $25.35 |
| Ezell Ryan Gillis | F | Oct 30, 2026 | 7,870 | $25.35 |
| ProFrac GDM, LLC | Sell | Sep 11, 2026 | 2,306,806 | $26.01 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $188.1M | $187.0M | $237.3M |
| Gross Profit | $24.3M | $39.4M | $59.8M |
| Operating Income | - | $12.2M | $23.2M |
| Net Income | $24.7M | $10.5M | $30.5M |
| Gross Margin | 12.9% | 21.1% | 25.2% |
| Op. Margin | - | 6.5% | 9.8% |
| Net Margin | 13.1% | 5.6% | 12.9% |
| Balance Sheet | |||
| Total Assets | $157.5M | $170.8M | $220.0M |
| Equity | - | $113.9M | $113.1M |
| ROE | - | 9.2% | 27.0% |
| Per Share | |||
| EPS | - | $0.34 | $0.84 |
| Cash Flow | |||
| Operating CF | - | $3.4M | $7.2M |
Source: XBRL data in FLOTEK INDUSTRIES INC/CN/ (FTK)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
FTK filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 18, 2026 | - | - | - |
| 4 | Nov 18, 2026 | - | - | - |
| 4 | Nov 16, 2026 | - | - | - |
| 10-Q | Nov 6, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 3, 2026 | - | Analysis | - |
| 4 | Nov 2, 2026 | - | - | - |
| 4 | Nov 2, 2026 | - | - | - |
| 8-K | Sep 23, 2026 | - | Analysis | - |
| 4 | Sep 15, 2026 | - | - | - |
| 4 | Sep 15, 2026 | - | - | - |
| 8-K | Sep 9, 2026 | - | Analysis | - |
| 8-K | Aug 19, 2026 | - | Analysis | - |
| 8-K | Aug 18, 2026 | - | Analysis | - |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 8-K | Aug 3, 2026 | - | Analysis | - |
| 4 | Jul 24, 2026 | - | - | - |
| 8-K | Jul 17, 2026 | - | Analysis | - |
| 4 | Jul 9, 2026 | - | - | - |
| 8-K | May 15, 2026 | - | Analysis | |
| 10-Q | May 7, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 5, 2026 | - | Analysis | - |
| 4 | Apr 6, 2026 | - | - | - |
| 4 | Mar 16, 2026 | - | - | - |
Related Health Care companies
- ASPI · ASP Isotopes Inc.Miscellaneous Chemical Products
- OEC · Orion S.A.Miscellaneous Chemical Products
- WDFC · WD 40 COMiscellaneous Chemical Products
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
FTK SEC filings: frequently asked questions
Are FTK insiders buying or selling?
In the last 90 days, FLOTEK INDUSTRIES INC/CN/ (FTK) officers, directors and 10% owners reported 1 open-market purchase worth $34.3 million by 1 insider and 6 open-market sales worth $61.8 million by 2 insiders on Form 4, a net sale of $27.5 million. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
What was FTK's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), FLOTEK INDUSTRIES INC/CN/ (FTK) reported revenue of $237.3 million (up 26.9% from FY2024) and net income of $30.5 million. Diluted EPS was $0.84. The figures come from the XBRL data in the 10-K.
What did FTK report in its latest 8-K?
FLOTEK INDUSTRIES INC/CN/ (FTK) filed an 8-K on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Flotek reported financial results for the quarter ended September 30, 2026.
What are the latest FTK SEC filings?
FLOTEK INDUSTRIES INC/CN/ (FTK) filed its latest 10-K annual report on March 16, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 3, 2026 and a Form 4 insider filing on November 19, 2026.
What is FTK's SEC CIK number?
FLOTEK INDUSTRIES INC/CN/ (FTK)'s SEC Central Index Key (CIK) is 928054. EDGAR lists every FTK filing under that number.
Ask anything about FTK
The research agent reads FTK's filings, financials, insider trades and 13F holders, then answers with sources.